Skip to main content
evidena care

Interactions

Tilidine: alternatives, switching and what doctors weigh up

Tilidine is a common painkiller in Germany, but it is no longer on the market in Switzerland. An alternative requires a switch planned by a doctor.

Key points

  • Tilidine is an opioid for moderate to severe pain. In Switzerland it was authorised as Valoron drops; distribution was discontinued in 2022.
  • Anyone moving from Germany or not tolerating tilidine needs a switch planned by a doctor. Stopping an opioid abruptly can trigger withdrawal symptoms and worse pain.
  • Cannabis is not a substitute for tilidine. A doctor can consider it as an add-on in individual cases; for chronic pain, studies mostly show small effects.

Tilidine is an opioid for moderate to severe pain. In Germany it is prescribed frequently, usually combined with naloxone. In Switzerland, tilidine was authorised as Valoron drops; distribution was discontinued in 2022. Anyone looking for a tilidine alternative here will therefore not find it at the pharmacy, but in a conversation with their doctor.1

Switching from tilidine to another painkiller belongs in a doctor’s hands. Do not stop tilidine on your own and do not replace it with another product, not even with cannabis. After longer use, stopping abruptly without medical supervision can trigger withdrawal symptoms and worse pain.4

What tilidine is and how it works

Tilidine is a so-called prodrug. It is only converted in the liver into nortilidine, which accounts for most of the effect. Nortilidine binds to μ-opioid receptors, like other opioids. The liver enzymes CYP3A4 and CYP2C19 are involved in the conversion. Medicines that inhibit these enzymes can therefore influence how much nortilidine is formed.1,2

In Germany, tilidine is usually combined in a fixed dose with naloxone. Naloxone blocks opioid receptors. When taken normally by mouth, it is largely broken down in the liver; the addition is mainly intended to make misuse harder. Common possible side effects of tilidine include dizziness, drowsiness, tiredness, nausea, vomiting, constipation and sweating, and at high doses respiratory depression.1

Tilidine in Switzerland: authorised, but no longer on the market

In Switzerland, tilidine had been authorised since 1975 as an oral solution. Unlike in Germany, the product sold here did not contain naloxone. Distribution was discontinued in 2022. There is therefore no Swiss replacement product with the same active substance.1

For people moving from Germany to Switzerland, this has a practical consequence: a German tilidine prescription cannot simply be continued here. Plan the move in advance with your current doctor and book an appointment in Switzerland early. Bring your current medication plan and medical reports. What applies to a German cannabis prescription when moving is described in the article German cannabis prescription when moving.

Why people look for a tilidine alternative

The reasons vary. Some people tolerate tilidine poorly, for example because of tiredness, nausea or constipation. Others worry about possible dependence: like all opioids, tilidine can be misused. Still others move to Switzerland, where tilidine is no longer available.1

With longer use of an opioid, the body gets used to the active substance. This is not yet addiction, but it means that withdrawal symptoms can occur if it is suddenly left out. The US guideline of the CDC recommends not ending opioid therapy abruptly after longer use, but reducing it gradually and together with the patient. It names withdrawal symptoms, worse pain and mental health crises, among others, as possible consequences of an abrupt stop.4

How a doctor plans a switch from tilidine

Which alternative is suitable depends on the type of pain, pre-existing conditions, liver and kidney function and the other medicines. Many doctors use the WHO analgesic ladder as a rough guide: it ranks painkillers from non-opioids through weaker to strong opioids. Depending on the source, tilidine is classed among the weaker or moderately strong opioids. The CDC guideline stresses that for many types of chronic pain, non-drug measures and non-opioids are considered first.4

Depending on the situation, options include:

  • other opioids, if an opioid is still needed; the doctor then converts the dose and monitors the first weeks,
  • non-opioid painkillers, alone or in combination,
  • co-analgesics for certain types of pain, such as nerve pain,
  • non-drug measures such as physiotherapy, exercise therapy or psychological pain therapy.

What matters is a switch without a gap. A doctor determines when the new medicine starts and how the previous one is reduced. The CDC guideline also recommends reassessing benefits and risks regularly and being particularly careful with high doses or simultaneous use of depressant medicines.4

Narcotics prescription for opioids in Switzerland

In Switzerland, strong opioids are classed as narcotics. For these, the doctor issues an official, numbered narcotics prescription. The prescription is valid for one month from the date of issue. At most the quantity needed for one month may be prescribed, or up to three months in justified cases.3

The same rules apply to cannabis medicines containing THC. What a narcotics prescription is, is explained in the glossary.3

Cannabis for pain: not a tilidine substitute, what studies show

Cannabis is not a substitute for tilidine or any other opioid. A doctor can consider a cannabis medicine for chronic pain in individual cases, usually as an add-on when the usual treatment is not sufficient or not tolerated. The FOPH states that sufficient clinical data are lacking for most uses.8

A meta-analysis of 32 randomised trials with 5174 adults found a small improvement in chronic pain compared with placebo: around 10 percent more participants achieved noticeable pain relief. Dizziness, tiredness, nausea and concentration problems were more frequent with cannabis.5

Whether cannabis reduces the need for opioids is unclear. In a review, observational studies did show a reduction, but the certainty of this evidence was very low. The randomised trials, all in cancer pain, found no clear effect on opioid use or pain. In an Australian cohort of 1514 people on opioid therapy, there was no indication over four years that cannabis use reduced opioid intake or improved pain.6,7

Anyone taking an opioid and also receiving cannabis must expect greater tiredness. More on this in the article Interactions of cannabis with medicines and in the overview Interactions.5

How it works at evidena

At evidena, the doctor decides after a consultation whether a cannabis medicine can be considered. Your ongoing pain therapy is not replaced; you discuss changes with the doctor who prescribes it. Bring your complete medication plan, including tilidine or other opioids from Germany. If a prescription is issued, it must be filled at a pharmacy within one month. The prescribed quantity normally covers one month, and at most three months of treatment in justified cases.3 You can book an appointment at https://portal.evidena.care/appointments. We answer questions via WhatsApp or at info@evidena.care. The process is described on the page How it works.

Conclusion

Tilidine is no longer on the market in Switzerland; the doctor chooses an alternative suited to your pain and medicines. Never stop an opioid abruptly and never on your own. Cannabis is not a substitute for tilidine, but a doctor can consider it as an add-on in individual cases, with modest study evidence.

Frequently asked questions

Is tilidine available in Switzerland?

Tilidine was authorised in Switzerland as Valoron drops; distribution was discontinued in 2022. The combination with naloxone that is common in Germany was not on the market here.

What is an alternative to tilidine?

Your doctor decides this based on the type of pain, pre-existing conditions and other medicines. Depending on the situation, options include other opioids, non-opioid painkillers and non-drug measures.

Can I simply stop taking tilidine?

No, not on your own. After longer use, stopping abruptly can trigger withdrawal symptoms, which is why a reduction is planned by a doctor.

Can cannabis replace tilidine?

No. Cannabis is not a substitute for an opioid. Whether it can be considered as an add-on in an individual case is assessed by your doctor; for chronic pain, studies mostly show small effects.

Do I need a narcotics prescription for an opioid in Switzerland?

In Switzerland, narcotics such as strong opioids require an official narcotics prescription. It is valid for one month from the date of issue.

Your situation is individual

Discuss your questions with a doctor.

Book a consultation

Sources

  1. Tilidin, PharmaWiki (accessed 11 November 2026)
  2. Grün B et al. Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine. Br J Clin Pharmacol. 2012;74(5):854-63. doi:10.1111/j.1365-2125.2012.04261.x
  3. Betäubungsmittelkontrollverordnung (BetmKV), SR 812.121.1, Art. 46 und 47, Fedlex (accessed 11 November 2026)
  4. Dowell D et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022. MMWR Recomm Rep. 2022;71(3):1-95. doi:10.15585/mmwr.rr7103a1
  5. Wang L et al. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ. 2021;374:n1034. doi:10.1136/bmj.n1034
  6. Noori A et al. Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies. BMJ Open. 2021;11(7):e047717. doi:10.1136/bmjopen-2020-047717
  7. Campbell G et al. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Lancet Public Health. 2018;3(7):e341-e350. doi:10.1016/S2468-2667(18)30110-5
  8. Behandlungsempfehlungen für den Einsatz von Cannabisarzneimitteln, Bundesamt für Gesundheit BAG, 17. Januar 2025 (accessed 11 November 2026)

Written by evidena.care editorial team · Published 11 November 2026 · Reviewed 13 November 2026

This article is general information and does not replace medical advice. Whether cannabis therapy is an option for you is decided by a doctor in a personal consultation.